TRKA yields 1503.76% · PFE yields 6.13%● Live data
📍 TRKA pulled ahead of the other in Year 1
Combined, TRKA + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of TRKA + PFE for your $10,000?
Troika Media Group, Inc. operates as a brand consulting and marketing agency specializing in the entertainment and sports media sectors worldwide. It offers media services and analytics platform, digital marketing, data analytics and reporting, media content for events and hospitality customers, sponsorship partnerships and advertising opportunities, analytics and big data; strategic media buying and planning, design and branding, market research and insights, brand strategy, 360 brand design, advertising and sponsorship integration, brand experience and fan engagement, content creation, and sonic branding and original music services, as well as design, animation, and post production studio services. The company also provides brand fundamentals development, brand voice and personality development, marketing strategy, public relations, crisis management, and physical and digital experiential services. It serves fashion, beauty, jewelry/watches, beverage alcohol, pharmaceuticals, entertainment, consumer goods, telco, tech, sports, and automotive industries, as well as non-profit organizations. The company was formerly known as M2 nGage Group, Inc. and changed its name to Troika Media Group, Inc. in July 2017. Troika Media Group, Inc. is headquartered in Los Angeles, California.
Full TRKA Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.